The CDDF’s article on “United efforts to accelerate drug development” has been published in the European Pharmaceutical Review (Dec, 2021).
In the article, Prof. John Smyth (Chairman), Prof. Axel Glasmacher (Treasurer) and Prof. Jaap Verweij (Managing Director) clarify the importance of a collaborative industry approach to cancer therapy development and highlight the most pressing challenges for discussion in CDDF meetings and workshops.
Read the full text here: European Pharmaceutical Reveiw_Dec2021